H.B. Fuller Reports 2.8% Revenue Decline in Q3 2025, Net Income Increases to $67.2 Million

H.B. Fuller Company reported a decrease in net revenue for the third quarter of 2025, totaling $892.0 million, down 2.8% from $917.9 million in the same period last year. The decline was attributed to a 2.9% decrease from acquisitions and divestitures, alongside a 1.9% drop in sales volume. However, this was partially offset by a 1.0% increase in pricing and a similar rise due to favorable currency effects. For the first nine months of 2025, net revenue also fell by 2.5% to $2.578 billion compared to $2.645 billion in 2024. Gross profit for the quarter increased to $285.1 million, reflecting a gross margin of 32.0%, up from 30.0% a year earlier, primarily due to higher product pricing and lower distribution costs.

The company's net income attributable to H.B. Fuller rose to $67.2 million in the third quarter, compared to $55.4 million in the prior year, resulting in diluted earnings per share of $1.22, up from $0.98. However, for the first nine months, net income decreased to $122.2 million from $137.6 million, with diluted earnings per share dropping to $2.21 from $2.43. The increase in net income for the quarter was supported by a significant rise in other income, which reached $5.3 million, compared to $2.1 million in the previous year.

Strategically, H.B. Fuller has been active in acquisitions, including the purchase of ND Industries Asia, Inc. for approximately $8.3 million, aimed at enhancing its presence in the Greater Asia market. Additionally, the company completed the acquisitions of GEM S.r.l. and Medifill Limited for a combined total of about $197 million, which are expected to bolster its medical adhesive offerings in Europe. The company also divested its North American Flooring business, which contributed to the revenue decline in the current reporting period.

Operationally, H.B. Fuller reported a total employee headcount of 6,500 as of August 30, 2025, reflecting ongoing restructuring efforts aimed at optimizing operations. The company has implemented restructuring plans expected to incur costs between $70 million and $75 million, with $69.7 million already expended as of the reporting date. The restructuring is anticipated to be completed by fiscal year 2026. The company also noted a decrease in trade receivables and inventory levels, which contributed to a cash flow impact of $71.2 million in the first nine months of 2025.

Looking ahead, H.B. Fuller remains focused on integrating its recent acquisitions and optimizing its operational structure. The company expects to continue leveraging pricing strategies to mitigate the impact of currency fluctuations and market conditions. Management anticipates that cash flows from operating activities will be sufficient to meet both short-term and long-term liquidity needs, while also maintaining compliance with its credit agreements.